Arsenic-induced alteration in the expression of genes related to type 2 diabetes mellitus

被引:83
作者
Diaz-Villasenor, Andrea [1 ]
Burns, Anna L.
Hiriart, Marcia
Cebrian, Mariano E.
Ostrosky-Wegman, Patricia
机构
[1] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Genom Med & Environm Toxicol, Mexico City 04510, DF, Mexico
[2] Univ Nacl Autonoma Mexico, Fac Med, Mexico City 04510, DF, Mexico
[3] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Biophys, Mexico City, DF, Mexico
[4] IPN, CINVESTAV, Secc Externa Toxicol, Mexico City, DF, Mexico
关键词
arsenic; type; 2; diabetes; gene expression; insulin; glucose;
D O I
10.1016/j.taap.2007.08.019
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Chronic exposure to high concentrations of arsenic in drinking water is associated with an increased risk for developing type 2 diabetes. The present revision focuses on the effect of arsenic on tissues that participate directly in glucose homeostasis, integrating the most important published information about the impairment of the expression of genes related to type 2 diabetes by arsenic as one of the possible mechanisms by which it leads to the disease. Many factors are involved in the manner in which arsenic contributes to the occurrence of diabetes. The reviewed studies suggest that arsenic might increase the risk for type 2 diabetes via multiple mechanisms, affecting a cluster of regulated events, which in conjunction trigger the disease. Arsenic affects insulin sensitivity in peripheral tissue by modifying the expression of genes involved in insulin resistance and shifting away cells from differentiation to the proliferation pathway. In the liver arsenic disturbs glucose production, whereas in pancreatic beta-cells arsenic decreases insulin synthesis and secretion and reduces the expression of antioxidant enzymes. The consequences of these changes in gene expression include the reduction of insulin secretion, induction of oxidative stress in the pancreas, alteration of gluconeogenesis, abnormal proliferation and differentiation pattern of muscle and adipocytes as well as peripheral insulin resistance. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:123 / 133
页数:11
相关论文
共 69 条
[11]   Arsenical-based cancer drugs [J].
Dilda, Pierre J. ;
Hogg, Philip J. .
CANCER TREATMENT REVIEWS, 2007, 33 (06) :542-564
[12]   Arsenite blocks growth factor induced activation of the MAP kinase cascade, upstream of Ras and downstream of Grb2-Sos [J].
Doza, YN ;
Hall-Jackson, CA ;
Cohen, P .
ONCOGENE, 1998, 17 (01) :19-24
[13]   Phosphorylation-dependent nucleocytoplasmic shuttling of pancreatic duodenal homeobox-1 [J].
Elrick, LJ ;
Docherty, K .
DIABETES, 2001, 50 (10) :2244-2252
[14]   Reactive species and early manifestation of insulin resistance in type 2 diabetes [J].
Fridlyand, LE ;
Philipson, LH .
DIABETES OBESITY & METABOLISM, 2006, 8 (02) :136-145
[15]  
Gaskin Robert St. C., 2001, Ethnicity and Disease, V11, P749
[16]   The genetic basis of type 2 diabetes mellitus: Impaired insulin secretion versus impaired insulin sensitivity [J].
Gerich, JE .
ENDOCRINE REVIEWS, 1998, 19 (04) :491-503
[17]   The enigma of arsenic carcinogenesis:: Role of metabolism [J].
Goering, PL ;
Aposhian, HV ;
Mass, MJ ;
Cebrián, M ;
Beck, BD ;
Waalkes, MP .
TOXICOLOGICAL SCIENCES, 1999, 49 (01) :5-14
[18]   Adipose tissue and adipokines: for better or worse [J].
Guerre-Millo, M .
DIABETES & METABOLISM, 2004, 30 (01) :13-19
[19]   PPARγ and metabolism:: insights from the study of human genetic variants [J].
Gurnell, M .
CLINICAL ENDOCRINOLOGY, 2003, 59 (03) :267-277
[20]   Molecular basis for effects of carcinogenic heavy metals on inducible gene expression [J].
Hamilton, JW ;
Kaltreider, RC ;
Bajenova, OV ;
Ihnat, MA ;
McCaffrey, J ;
Turpie, BW ;
Rowell, EE ;
Oh, J ;
Nemeth, MJ ;
Pesce, CA ;
Lariviere, JP .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1998, 106 :1005-1015